Cisplatin treatment for oropharyngeal cancer

Author: nmgj

August undefined, 2024

WebMay 27, 2024 · The majority of newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) is associated with human papillomavirus (HPV) infection, portending very good … WebMay 22, 2024 · Pembrolizumab monotherapy significantly improved overall survival in patients with squamous cell carcinoma of the head and neck (HNSCC) and a PD-L1 combined positive score (CPS) of > 1 and > 20 compared …

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin …

WebApr 15, 2024 · The trial will directly compare clinical outcomes related to de-intensification strategies in HPV-positive oropharyngeal disease through use of both reduced intensity radiation and/or nivolumab therapy. Similar to NRG-HN004 in cisplatin-ineligible patients, immune checkpoint therapy is added to augment RT-induced immunogenic cell death … WebIt can therefore be hypothesised that some of these patients would benefit from an intensified local treatment, such as radiation dose escalation of the primary tumour. This … reach immigration qatar

Dose escalation in oropharyngeal cancer: a comparison of …

WebMay 6, 2024 · The standard treatment of early-stage HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) includes one or a combination of surgery, radiation, … WebCisplatin is also sometimes used to treat head and neck cancer (including cancer of the mouth, lip, cheek, tongue, palate, throat, tonsils, and sinuses), lung cancer, cancer of … WebOct 22, 2024 · This study shows that the best treatment choice for patients with HPV-positive throat cancer is cisplatin and radiotherapy. This combination gives ‘double’ the benefit since it is more effective in terms of survival and does not worsen all grade toxicity compared to cetuximab with radiotherapy.” reach immigration jeddah

KEYNOTE-048: A Phase III Study of First-Line Pembrolizumab for ...

[Means of improvement of surgical treatment for oropharyngeal ...

WebThe treatment of locally advanced head and neck cancer (HNC) is based on extensive resections followed by concurrent chemoradiotherapy (CRT) with platinum derivatives or concurrent radiotherapy with cetuximab (bioradiotherapy; BRT). Malnutrition, which occurs in up to 60% of patients before treatment commencement, severely increases the risk of … WebDec 15, 2024 · Various trials have examined induction cisplatin-based chemotherapy followed by reduced radiation doses or volumes. Induction chemotherapy can be used for risk stratification with the assumption that adjuvant RT can be reduced in good responders. reach import limitsWebDec 3, 2024 · The oropharyngeal areas mainly comprises of the tonsil, base tongue (BOT), soft palate and the posterior pharyngeal wall. Traditionally, surgical resection of oropharyngeal cancers (OPC) was a standard procedure, often performed through mutilating incisions with mandibulotomies, rendering significant post-operative functional … how to stabilize a wobbly desk

"WebApr 4, 2024 · Cisplatin (Category 1 for high-risk non-oropharyngeal cancers) 14–19. Days 1, 22, and 43: Cisplatin 100mg/m 2 IV + radiotherapy. Induction Chemotherapy b … " - Cisplatin treatment for oropharyngeal cancer

Cisplatin treatment for oropharyngeal cancer

ESMO Press Release Cetuximab vs cisplatin HPV+ oropharyngeal cancer …

WebFeb 24, 2024 · Oropharyngeal cancer treatment options may include radiation therapy, surgery, chemoradiation, chemotherapy alone, and immunotherapy. Get detailed information about the treatment for newly diagnosed and recurrent oropharyngeal cancer … Treatment of Head and Neck Cancer in Children and Adolescents—Patient … WebFeb 2, 2024 · The benefit of adding concomitant high-dose cisplatin to adjuvant radiotherapy (RT) for resected head and neck squamous cell carcinoma (HNSCC) was established in two large seminal trials, EORTC 22931 and RTOG 9501. 1 - 3 In these studies, cisplatin was administered at a dose of 100 mg/m 2 on days 1, 22, and 43 …

Did you know?

WebCisplatin is the standard cytotoxic agent that has been used ... Mady LJ, Baddour K, Hodges JC, et al. The impact of frailty on mortality in non-surgical head and neck cancer treatment: shifting the clinical paradigm. ... Egerman MA, Bui AH, et al. A new face of the HPV epidemic: oropharyngeal cancer in the elderly. Oral Oncol. 2024;109:104687 ... WebJan 7, 2024 · Cisplatin treatment was administered as a triweekly regimen, which differs from this study where weekly, low-dose treatment was used. There was a significantly increased risk of grade 3 increase in serum-creatinine (3.0 to 6.0 times the upper limit of normal serum-creatinine) in the saline group.

WebJan 7, 2024 · Cisplatin treatment was administered as a triweekly regimen, which differs from this study where weekly, low-dose treatment was used. There was a significantly … WebA new technique of intraoperative bolus-assisted administration of chemical drugs for oropharyngeal carcinoma has been developed. In tongue tumor, the lingual artery was ligated at the site of origin from the external carotid artery and catheter was installed after venous flow was blocked.

WebFeb 16, 2016 · Purpose: Loco-regional control and organ preservation are significantly improved with concomitant cisplatin/radiotherapy and are compromised with less than 5% grade 3 nephrotoxicity (creatinine clearance 15–29 mL/min). However, although clinically important, in none of the randomized trials is grade 2 nephrotoxicity (defined as … WebSep 15, 2024 · Aluminum reacts with cisplatin (cisplatin injection) , causing precipitate formation and a loss of potency. Metastatic Testicular Tumors - The usual cisplatin …

WebJul 1, 2024 · Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings …

WebOct 22, 2024 · This study shows that the best treatment choice for patients with HPV-positive throat cancer is cisplatin and radiotherapy. This combination gives ‘double’ the … reach impact ukraineWebApr 7, 2024 · Local recurrence is the most common pattern of failure in head and neck cancer. It can therefore be hypothesised that some of these patients would benefit from an intensified local treatment, such as radiation dose escalation of the primary tumour. This study compares treatment and toxicity outcomes from two different boost modalities in … reach imhWebJun 6, 2024 · Results of our study show that, in the setting of low-risk oropharyngeal squamous cell carcinoma, the use of cetuximab bioradiotherapy instead of cisplatin-based chemoradiotherapy resulted in no overall benefit in terms of toxicity but showed significant detriment in tumour control. reach illinoisWebApr 11, 2024 · Eisenberger M, Hornedo J, Silva H, et al. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1986; 4:1506. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008; 359:1116. reach immigration ammanWebApr 12, 2024 · The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: the prospective PLATISMA study. Eur. J. Cancer 160, 92–99 (2024). •• Pivotal study investigating the mechanism of cisplatin toxicity in sarcopenia.Crossref, Medline, CAS, Google Scholar; 46. Lutz CT, Quinn LS. reach importationWebCisplatin chemoradiotherapy provided more QALYs and was less costly than cetuximab bioradiotherapy, remaining standard of care for nonsurgical treatment of HPV-positive … reach impact assessmentWebOct 1, 2024 · All OPSCC patients were treated either with definitive cisplatin-chemoradiotherapy (CRT) or with definitive radiotherapy (RT) based on standard clinical … reach impact job